Clinical Trial Update: Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease [Phase 3]

View source ↗

Summary

Open-label Phase 3 study of levodopa-carbidopa intestinal gel in advanced Parkinson's disease has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa-carbidopa intestinal gel (levodopa-carbidopa intestinal gel)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Advanced Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-01-16